1.0Napo Therapeuticshttps://napotherapeutics.com/en/jamareahttps://napotherapeutics.com/en/author/jamarea/Application for O.D.D. for Crofelemer, a rare gastrointestinal pathology - Napo Therapeuticsrich600338<blockquote class="wp-embedded-content" data-secret="dcXvY7NJsX"><a href="https://napotherapeutics.com/en/2022/09/12/orphan-drug-designation-crofelemer/">Application for O.D.D. for Crofelemer, a rare gastrointestinal pathology</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://napotherapeutics.com/en/2022/09/12/orphan-drug-designation-crofelemer/embed/#?secret=dcXvY7NJsX" width="600" height="338" title="“Application for O.D.D. for Crofelemer, a rare gastrointestinal pathology” — Napo Therapeutics" data-secret="dcXvY7NJsX" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://napotherapeutics.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://napotherapeutics.com/wp-content/uploads/2022/09/newscomunicato-1.webp19201280E’ stata presentata a maggio all'Agenzia europea dei medicinali (EMA) una richiesta per il riconoscimento dello status di farmaco orfano al Crofelemer per una rara forma di diarrea cronica (CDD) chiamata malattia da inclusioni microvillari (MVID).